Gene · 9476
Papers2,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gelatinous pleural effusion in advanced lung adenocarcinoma: a case report. | J Med Case Rep | 2025 | 40817064 | PubTator, text mining | PubMed |
| Diabetes insipidus as a presentation of lung adenocarcinoma: a case report. | J Med Case Rep | 2025 | 40804421 | PubTator, text mining | PubMed |
| Primary pulmonary enteric adenocarcinoma in a young adult: a diagnostic and therapeutic challenge. | BMJ Case Rep | 2025 | 40789705 | PubTator, text mining | PubMed |
| SMARCB1/INI1-deficient lung cancer with lymph node metastasis: a case report and literature review. | AME Case Rep | 2025 | 40761191 | PubTator, text mining | PubMed |
| First case report of immune checkpoint inhibitor therapy to treat secretory carcinoma. | Ther Adv Med Oncol | 2025 | 40755831 | PubTator, text mining | PubMed |
| Evaluation of TTF-1, Napsin A, p40, and p63 in the Subtyping of Non-Small Cell Lung Carcinoma: A Cross-Sectional Study from India. | Iran J Pathol | 2025 | 40746930 | PubTator, text mining | PubMed |
| Adenocarcinoma and squamous cell carcinoma in the same lobe of the lung with adenocarcinoma metastasis in the lymph nodes: a case report and literature review. | Front Oncol | 2025 | 40746613 | PubTator, text mining | PubMed |
| Rare Case of Duodenal Metastasis From Colon Cancer: Review of Literature and Insights on Novel Therapies. | Case Rep Gastrointest Med | 2025 | 40740271 | PubTator, text mining | PubMed |
| Metastatic Lung Adenocarcinoma Presenting With Cavitary and Consolidative Lung Findings: A Diagnostic Dilemma. | Case Rep Oncol Med | 2025 | 40708867 | PubTator, text mining | PubMed |
| A nomogram model integrating radiomics and clinical variables to predict napsin a expression in lung adenocarcinoma patients. | Front Oncol | 2025 | 40687424 | PubTator, text mining | PubMed |
| Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer. | J Immunother Cancer | 2025 | 40664448 | PubTator, text mining | PubMed |
| Case Report: Three cases of lung large cell neuroendocrine carcinoma with clinicopathological features of SMARCA4 (BRG1) deficiency. | Front Oncol | 2025 | 40661782 | PubTator, text mining | PubMed |
| Clinicopathologic characteristics and outcome of gastric-type endocervical adenocarcinoma: a single-center retrospective study. | Int J Clin Exp Pathol | 2025 | 40642390 | PubTator, text mining | PubMed |
| Acantholytic squamous cell carcinoma of the lung with pseudoglandular features: clinicopathologic study of 14 cases. | Virchows Arch | 2025 | 40608132 | PubTator, text mining | PubMed |
| Distal pulmonary epithelial maturation in preterm infants: does the lung of the preterm infant continue its functional pulmonary development postnatally? | J Med Life | 2025 | 40599141 | PubTator, text mining | PubMed |
| Leptomeningeal metastasis with sturge-weber syndrome-like gyriform calcification on imaging: a case report. | BMC Neurol | 2025 | 40597070 | PubTator, text mining | PubMed |
| Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas. | Lung Cancer | 2025 | 40592197 | PubTator, text mining | PubMed |
| Oncogenic ALK fusion in rare subtype of small intestine metastasis from occult lung cancer. | Lung Cancer Manag | 2025 | 40583697 | PubTator, text mining | PubMed |
| Immunohistochemical TTF-1 and Napsin a Expression in Gastrointestinal Adenocarcinomas-Low Frequency but an Important Pitfall. | Diagnostics (Basel) | 2025 | 40564811 | PubTator, text mining | PubMed |
| Histopathological examination of lung from infant with lethal COVID-19 with special attention on pneumocytes type II and the immune infiltrate: a case study. | Ital J Pediatr | 2025 | 40483512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9476/papers?page=8